Literature DB >> 9715680

Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome.

K C Chern1, D Conrad, G N Holland, D S Holsclaw, L K Schwartz, T P Margolis.   

Abstract

OBJECTIVE: To characterize further a chronic epithelial keratitis caused by varicella-zoster virus infection in patients with acquired immunodeficiency syndrome (AIDS).
METHODS: Patients with AIDS and chronic epithelial keratitis associated with varicella-zoster virus from 3 institutions were identified. Patient records were reviewed retrospectively for the following data: medical and demographic characteristics, techniques of diagnosis, physical findings, course, response to treatment, and outcome.
RESULTS: Sixteen patients were studied. CD4+ T-lymphocyte cell counts were available in 11 patients, with a median of 0.034 x 10(9)/L (range, 0-0.094 x 10(9)/L). Two patients had no history of a zosteriform rash. In the remaining patients, the interval between rash and keratitis ranged from 0 days to 6 years. In all cases, the keratitis was chronic and characterized by gray, elevated, dendriform epithelial lesions that stained variably with fluorescein and rose bengal. The peripheral and midperipheral cornea was most commonly affected, and, in 13 of the 16 patients, the lesions crossed the limbus. Pain was a prominent feature, occurring in 12 of 16 patients. In 9 of 12 patients tested, varicella-zoster virus was identified by culture, direct fluorescent antibody testing, polymerase chain reaction testing, or a combination of these studies, with direct fluorescent antibody testing (6 of 8 positive results) and polymerase chain reaction testing (3 of 3 positive results) appearing to be the most sensitive. Response to antiviral medication was variable.
CONCLUSIONS: In patients with AIDS, varicella-zoster virus may cause a chronic infection of the corneal epithelium. The keratitis is characterized by dendriform lesions, prolonged course, and frequently by extreme pain. It can occur without an associated dermatitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715680     DOI: 10.1001/archopht.116.8.1011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

1.  Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus.

Authors:  Aileen Sy; Stephen D McLeod; Elisabeth J Cohen; Todd P Margolis; Mark J Mannis; Thomas M Lietman; Nisha R Acharya
Journal:  Cornea       Date:  2012-07       Impact factor: 2.651

2.  Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus.

Authors:  Allen Y H Hu; Erich C Strauss; Gary N Holland; Matilda F Chan; Fei Yu; Todd P Margolis
Journal:  Am J Ophthalmol       Date:  2009-11-11       Impact factor: 5.258

Review 3.  Pathobiology and treatment of viral keratitis.

Authors:  Raghuram Koganti; Tejabhiram Yadavalli; Raza Ali Naqvi; Deepak Shukla; Afsar R Naqvi
Journal:  Exp Eye Res       Date:  2021-02-06       Impact factor: 3.467

4.  Ocular and neural distribution of feline herpesvirus-1 during active and latent experimental infection in cats.

Authors:  Wendy M Townsend; Susan Jacobi; Shih-Han Tai; Matti Kiupel; Annabel G Wise; Roger K Maes
Journal:  BMC Vet Res       Date:  2013-09-22       Impact factor: 2.741

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.